Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology | Family Medicine
 Disease Category: High Blood Pressure (Hypertension)
Location: United States, CA

Trial Information

The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive patients With Impaired Glucose Tolerance or Impaired Fasting Glucose

Blood Pressure and Metabolic Effects of Nebivolol Compared with Hydrochlorothiazide and Placebo in Hypertensive patients with Impaired Glucose Tolerance or Impaired Fasting Glucose.

Inclusion Criteria:

  • Male or female, ambulatory outpatients 18-80 years old at screening.
  • Have a history of hypertension
  • Qualifying laboratory results

Exclusion Criteria:

  • Severe Hypertension, including chronic renal disease
  • Use of niacin or anti-diabetic medication (oral or injectable) within 6 months of study
  • Have clinically significant respiratory, liver, or cardiovascular disease
  • Presence of coronary artery disease requiring treatment with a beta blocker, calcium channel blocker or nitrates
  • Have a history of hypersensitivity to nebivolol, other beta-blockers, or other sulfonomide-derived drugs.

Diablo Clinical Research
1365 Corte Loma
Walnut Creek, CA 94598
Phone: 925-930-7267
Fax: 925-930-7392

View Map

Research Center Information: Diablo Clinical Research

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.